269 related articles for article (PubMed ID: 15561303)
1. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications.
Nguewa PA; Fuertes MA; Valladares B; Alonso C; Pérez JM
Prog Biophys Mol Biol; 2005 May; 88(1):143-72. PubMed ID: 15561303
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
Horvath EM; Szabó C
Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
[TBL] [Abstract][Full Text] [Related]
3. Toward specific functions of poly(ADP-ribose) polymerase-2.
Yélamos J; Schreiber V; Dantzer F
Trends Mol Med; 2008 Apr; 14(4):169-78. PubMed ID: 18353725
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.
Jagtap P; Szabó C
Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271
[TBL] [Abstract][Full Text] [Related]
5. Detection of the nuclear poly(ADP-ribose)-metabolizing enzymes and activities in response to DNA damage.
Amé JC; Hakmé A; Quenet D; Fouquerel E; Dantzer F; Schreiber V
Methods Mol Biol; 2009; 464():267-83. PubMed ID: 18951190
[TBL] [Abstract][Full Text] [Related]
6. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
Sukhanova MV; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
[TBL] [Abstract][Full Text] [Related]
7. Physiology and pathophysiology of poly(ADP-ribosyl)ation.
Bürkle A
Bioessays; 2001 Sep; 23(9):795-806. PubMed ID: 11536292
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.
Masutani M; Nakagama H; Sugimura T
Cell Mol Life Sci; 2005 Apr; 62(7-8):769-83. PubMed ID: 15868402
[TBL] [Abstract][Full Text] [Related]
9. [Poly(ADP-ribose) polymerase (PARP): physiological and pathological roles].
Makogon NV; Aleksieieva IM
Fiziol Zh (1994); 2012; 58(3):95-112. PubMed ID: 22946318
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosyl)ation regulation of life and death in the nervous system.
Koh DW; Dawson TM; Dawson VL
Cell Mol Life Sci; 2005 Apr; 62(7-8):760-8. PubMed ID: 15868401
[TBL] [Abstract][Full Text] [Related]
11. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.
Tentori L; Portarena I; Graziani G
Pharmacol Res; 2002 Feb; 45(2):73-85. PubMed ID: 11846617
[TBL] [Abstract][Full Text] [Related]
12. Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes.
Cesarone CF; Pippia P; Demori I; Scarabelli L; Fugassa E
J Gravit Physiol; 2001 Jul; 8(1):P127-8. PubMed ID: 12650200
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation, PARP, and aging.
Beneke S; Bürkle A
Sci Aging Knowledge Environ; 2004 Dec; 2004(49):re9. PubMed ID: 15590998
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase-1 in the nervous system.
Ha HC; Snyder SH
Neurobiol Dis; 2000 Aug; 7(4):225-39. PubMed ID: 10964595
[TBL] [Abstract][Full Text] [Related]
15. Chromatin architecture and functions: the role(s) of poly(ADP-RIBOSE) polymerase and poly(ADPribosyl)ation of nuclear proteins.
Faraone-Mennella MR
Biochem Cell Biol; 2005 Jun; 83(3):396-404. PubMed ID: 15959565
[TBL] [Abstract][Full Text] [Related]
16. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
18. [PARP inhibitors for cancer therapy].
Saito H; Miki Y
Gan To Kagaku Ryoho; 2011 Jan; 38(1):12-8. PubMed ID: 21368455
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
Cepeda V; Fuertes MA; Castilla J; Alonso C; Quevedo C; Soto M; Pérez JM
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):39-53. PubMed ID: 18221025
[TBL] [Abstract][Full Text] [Related]
20. PARPs and the DNA damage response.
Sousa FG; Matuo R; Soares DG; Escargueil AE; Henriques JA; Larsen AK; Saffi J
Carcinogenesis; 2012 Aug; 33(8):1433-40. PubMed ID: 22431722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]